Results 211 to 214 of about 854,863 (214)

Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma

Annals of Oncology, 2015
Philip R. Debruyne, R Elaidi, M Gross-Goupil   +2 more
exaly  

Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation

ACS Medicinal Chemistry Letters, 2015
Nicole C Goodwin, Giovanni Cianchetta, Jason Allen   +2 more
exaly  

Synthesis of 3-(1-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor

Bioorganic and Medicinal Chemistry Letters, 2007
Ronghui Lin, Shenlin Huang, Peter J Connolly   +2 more
exaly  

Danusertib, an aurora kinase inhibitor

Expert Opinion on Investigational Drugs, 2012
Mathijssen Ron, Ronald De Wit, Jaap Verweij   +2 more
exaly